PRQR compared with NXTC: revenue, margins and what each company keeps, and the suppliers and customers both name

PRQRProQR Therapeutics N.V.

Mkt capRevenueRevenue

NXTCNextCure, Inc.

Mkt capRevenueRevenue

Compare

PRQRProQR Therapeutics N.V.

NXTCNextCure, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PRQR: latest quarter not drawable. NXTC: latest quarter not drawable.Method ›

Price

rebased to 0%

PRQR, solidNXTC, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PRQR 1

LLYEli Lillycustomer

Shared 0

No shared counterparties.

Only NXTC 7

—LigaChem Biosciences, Inc., formerly known as LegoChem Biosciences, Inc ("LigaChem")unlistedsupplier

—Simcere Zaiming Pharmaceutical Co., Ltd. (formerly known as Hainan Simcere Zaiming Pharmaceutical, Ltd. or hereinafter "Zaiming")unlistedsupplier

—WuXi XDC

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlisted

supplier

—Yale University ("Yale")unlistedsupplier

3 more · NXTC chain ›

PRQRProQR Therapeutics N.V.

1.38▼−4.31%· post 1.43

Mkt cap$146.5M

NXTCNextCure, Inc.

6.50▼−0.38%· post 6.18

ClosedOct 30 '26

Mkt cap$28.9M

Compare

ClosedOct 30 '26

PRQRProQR Therapeutics N.V.

NXTCNextCure, Inc.

1.38▼−4.31%post 1.43

Price

6.50▼−0.38%post 6.18

$146.5M

Mkt cap

$28.9M

PRQR1.38▼−4.31%vsNXTC6.50▼−0.38%ClosedOct 30 '26